Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HGH HoldingsSGX:5GZ ROE % is 14.10% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 3,001 Industrial Products companies, HGH Holdings ranks better than 70.81% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. HGH Holdings's annualized net income for the quarter that ended in Dec. 2025 was S$6.98 Mil. HGH Holdings's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was S$49.50 Mil. Therefore, HGH Holdings's annualized ROE % for the quarter that ended in Dec. 2025 was 14.10%.
The historical rank and industry rank for HGH Holdings's ROE % or its related term are showing as below:
SGX:5GZ'
s ROE % Range Over the Past 10 Years
Min: -10.26 Med: -3.9 Max: 78.81
Current: 10.79
During the past 13 years, HGH Holdings's highest ROE % was 78.81%. The lowest was -10.26%. And the median was -3.90%.
SGX:5GZ's ROE % is ranked better than 70.81% of 3001
companies
in the Industrial Products industry
Industry Median: 5.85
vs SGX:5GZ: 10.79
HGH Holdings (SGX:5GZ) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
HGH Holdings ROE % Related Terms
HGH Holdings ROE % Historical Data
* Premium members only.
The historical data trend for HGH Holdings's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, HGH Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HGH Holdings ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, HGH Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where HGH Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
HGH Holdings (SGX:5GZ) has a ROE % of 14.10% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on HGH Holdings and its competitors. According to the industry distribution chart, HGH Holdings ranks #876 out of 3001 companies in the Industrial Products industry, placing it in the top 29.2%.
Is HGH Holdings' ROE % too high?
HGH Holdings' current ROE % is 14.10%. The Industrial Products industry median ROE % is 5.85. HGH Holdings' value of 14.10% is 141% above this industry median. Based on the distribution chart, HGH Holdings ranks #876 out of 3001 companies in the Industrial Products industry, which is above the industry midpoint.
How does HGH Holdings' ROE % compare to VRT and BE?
According to the Industrial Products industry distribution chart, HGH Holdings ranks #876 out of 3001 companies for ROE %. This puts HGH Holdings in the upper half of its industry. The industry median ROE % is 5.85. HGH Holdings' value of 14.10% is 141% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.85, based on 3,001 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HGH Holdings's current ROE % of 14.10% is 141% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on HGH Holdings and its competitors. For the Industrial Products industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HGH Holdings's current ROE % is 14.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HGH Holdings stock overvalued right now?
Based on GuruFocus' analysis, HGH Holdings (SGX:5GZ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.04, compared to a current price of S$0.02 — trading 62.5% below its estimated fair value. The current ROE % is 14.10% and 141% above the Industrial Products industry median of 5.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For HGH Holdings (SGX:5GZ), the current ROE % is 14.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HGH Holdings Ltd, through its subsidiaries, is engaged in the supply and manufacturing of ready-mix concrete products; supply of precast concrete products; providing one-stop high value-added general warehousing and logistics services, industrial, office space for engineering, manufacturing, industrial training, and workers' dormitory facilities; and providing underground cable installation and road reinstatement services. Its segments include leasing and service income, the Manufacturing of Precast Concrete products, the Supply and Manufacturing of Ready-Mix Concrete products; and the provision of Underground Cable Installation and Road Reinstatement.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:5GZ has been successfully added to your 
